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Abstract
Background/Aims: Trafficking, brush border membrane (BBM) retention, and signal-specific 
regulation of the Na+/H+ exchanger NHE3 is regulated by the Na+/H+ Exchanger Regulatory 
Factor (NHERF) family of PDZ-adaptor proteins, which enable the formation of multiprotein 
complexes. It is unclear, however, what determines signal specificity of these NHERFs. Thus, we 
studied the association of NHE3, NHERF1 (EBP50), NHERF2 (E3KARP), and NHERF3 (PDZK1) 
with lipid rafts in murine small intestinal BBM. Methods: Detergent resistant membranes 
(“lipid rafts”) were isolated by floatation of Triton X-incubated small intestinal BBM from a 
variety of knockout mouse strains in an Optiprep step gradient. Acid-activated NHE3 activity 
was measured fluorometrically in BCECF-loaded microdissected villi, or by assessment of CO2/
HCO3
- mediated increase in fluid absorption in perfused jejunal loops of anethetized mice. 
Results: NHE3 was found to partially associate with lipid rafts in the native BBM, and NHE3 raft 
association had an impact on NHE3 transport activity and regulation in vivo. NHERF1, 2 and 3 
were differentially distributed to rafts and non-rafts, with NHERF2 being most raft-associated 
and NHERF3 entirely non-raft associated. NHERF2 expression enhanced the localization 
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of NHE3 to membrane rafts. The use of acid sphingomyelinase-deficient mice, which have 
altered membrane lipid as well as lipid raft composition, allowed us to test the validity of 
the lipid raft concept in vivo. Conclusions: The differential association of the NHERFs with 
the raft-associated and the non-raft fraction of NHE3 in the brush border membrane is one 
component of the differential and signal-specific NHE3 regulation by the different NHERFs.   
IntroductionNa+/H+ exchangers regulate salt and water absorption and maintain systemic pH within the physiological range [1]. NHE3, encoded by slc9a3 in mice [2, 3], is the major absorptive Na+/H+ exchanger in intestinal and renal epithelium [4], where it is expressed in the apical membrane and in recycling endosomes [5]. It is involved in electroneutral Na+ absorption from the lumen, a mechanism driven by the electrochemical gradient maintained by the activity of the Na+/K+‑ATPase pump on the basolateral membrane [6, 7]. Nhe3‑/‑ mice have an absorptive defect in the intestine and the kidney, mild acidosis, and a shortened lifespan [4].
Post-translational modifications, particularly phosphorylation [8], interactions with cytoskeletal elements [9], and electrostatic interactions of the cationic cytoplasmic tail of 
NHE3 with polyanionic lipids at the inner leaflet of the plasma membrane [10] alter NHE3 activity. The members of the Na+/H+ Exchanger Regulatory Factor (NHERF) family of PDZ‑adaptor proteins interact with the C‑terminal cytoplasmic domain of transporters and channels such as NHE3, Down Regulated in Adenoma (DRA), Putative Anion Transporter1 (PAT1) and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), and form multi‑molecular assemblies with the underlying cytoskeleton and associated proteins, 
thereby modulating such diverse processes as protein trafficking, membrane retention and the 
formation of signaling platforms [8, 11-13]. These highly homologous NHERF PDZ-adaptors, though expressed in the same spatiotemporal coordinates of the apical epithelial membrane, are not functionally redundant. They have been shown to differentially regulate NHE3 in 
response to specific agonists [14-18]. Currently, targeting NHERF-mediated multicomplex formation by small molecules is considered a technically challenging, but highly desirable drug development strategy.An additional aspect of regulation of apical NHE3 is the membrane lipid environment 
[10] and the association of NHE3 with cholesterol and sphingolipid-enriched membrane 
rafts (“lipid rafts”) [19, 20]. Defined biochemically, rafts resist solubilisation in nonionic detergents, enabling them to be separated as detergent resistant membranes (DRMs) by 
flotation in density gradients [21]. NHE3 has been reported to be partially raft-associated in rabbit ileum [19], and substantially raft‑associated in rat renal epithelium [22, 23]. It was 
further shown in opossum kidney cells that ~50% NHE3 localized to rafts, and this pool was 
functionally active, since methyl-β cyclodextrin (MβCD)-mediated disruption of membrane 
rafts decreased NHE3 activity [20]. Due to their inherent protein-lipid oligomerizing interactions, membrane rafts are believed to enable cosegregation and thus functional interaction of proteins in biological membranes [24]. This function of rafts is similar to that rendered by the NHERFs – the assembly of multimolecular complexes. Both rafts and NHERF‑PDZ scaffolds interact structurally with the cytoskeletal elements [6, 25]. In the 
targeting and localization of NHE3 to brush border membrane (BBM), it is not clear if there is any crosstalk between membrane rafts and NHERF PDZ‑adaptors.In this study, we have addressed the proportions of the NHE3 pool in the native murine small intestinal brush border membrane which associates with raft and non‑rafts, respectively, and tested whether this raft association of NHE3 has implications for transport function. We then studied the co‑segregation of NHERF1‑3 with the raft‑associated and the non‑raft pools of NHE3 and observed a differential association of the different NHERFs with the raft and the non‑raft pools of NHE3. 
 Copyright © 2013 S. Karger AG, Basel
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Material and Methods
MaterialsChemicals were obtained from Sigma‑Aldrich and Applichem. 2’, 7’‑bis (carboxyethyl)‑5, 
6-carboxyfluorescein (BCECF) was from Invitrogen. Hoe642 was kindly provided by Sanofi-Aventis (Frankfurt, Germany). OptiPrep gradient was from PROGEN Biotechnik (Germany). Rabbit Polyclonal 
anti-rat NHE3 IgG was used at a dilution of 1:2000 (Alpha Diagnostic). Mouse flotillin2 antibody was used 
at a dilution of 1:2000 (Santacruz Biotechnologies). Rabbit NHERF1 (Ab5199) and NHERF2 (Ab 2170) 
antibodies were used at 1:10,000 and 1:5000 dilutions, respectively (Prof. Chris C. Yun, Emory Univ., 
Atlanta). Rabbit PDZK1/NHERF3 peptide-1 was used at dilutions of 1:2000 (Prof. Hugo deJonge, Erasmus 
MC, Rotterdam). Rabbit Ezrin antibody was used at a dilution of 1:1000 (Cell Signaling). The anti-rabbit and 
anti-mouse, HRP-conjugated secondary antibodies were used at a dilution of 1:10,000 (Abcam). 
Mice strainsAcid sphingomyelinase (ASM)‑/‑ mice were generated at the laboratory of E. Schuchman [26] and congenic on the C57B/6 backround. Genotyping was done by PCR as previously described [26]. Nherf1‑/‑ 
mice were generated in the laboratory of E.J. Weinman as described earlier [27]. Nherf2‑/‑ mice were 
originally generated from Lexicon genetics clone OST2298 [28]. Nherf3‑/‑ mice were originally generated in the laboratory of O. Kocher [29]. All NHERF mice were congenic on the FVB/N background to ensure 
identical background for all NHERF deficient strains. Nhe3 ‑/‑ mice were originally generated in the lab of Gary Shull [4], and bred on both a congenic FVB/N and C57B/6 background. Dra‑/‑ mice were originally bred 
in the laboratory of C. Schweinfest [30] and maintained as described in [31]. PAT1 mice were generated as described in [32] and maintained as described in [31]. Age and sex‑matched wild type mice were used as 
controls. The animals were provided with standardized light and climate conditions with access to chow and water ad libitum. Animal experiments followed approved protocols of the Hannover Medical School and the local authorities for the regulation of animal welfare.
Preparation of isolated intestinal villi for fluorometryFor measuring pHi in isolated jejunal villi, the proximal jejunum (approximately 6cm distal to the pylorus) was removed and immediately placed in ice‑cold Ringer solution, solution composition in mM:147 NaCl, 4 KCl, 2.2 CaCl2 in 500µM DTT to prevent mucus clogging of the villi, pH 7.4 as previously described [33].
Fluorometric pHi measurements in intact villiFor the assessment of acid‑activated NHE3 activity in intact microdissected jejunal villi, the technique 
was used as described by Chen et al. [18, 33] with minor modifications. Villous enterocytes were acidified to pHi ~6.4 by a brief incubation with a buffer in which 40 mM NaCl was replaced by 40 mM NH4Cl for 5 min, followed by a buffer in which all Na+ was replaced by TMA. Acid‑activated Na+/H+ exchange activity was assessed as the initial rate of pH recovery after the Na+‑free buffer was switched to Na+‑containing buffer C (25 NaCl, 95 TMACl, 10 Hepes, 5 Tris, 2.25 KH2PO4, 1.5 K2HPO4, 1.2 MgSO4, 1.2 Ca-gluconate, 10 glucose, pH 7.4 gassed with oxygen): 50μM HOE642 was present both in Na+‑free buffer and Na+‑containing buffer 
C in the first recovery pulse to eliminate the contribution of NHE1 and NHE2: both 50μM HOE642 and 10 
µM S1611 (NHE3 specific inhibitor) were present during the recovery from a second ammonium prepulse to inhibit also NHE3 activity. Emission intensity ratio into pH calibration was performed as described in 
[34]. The rates of pHi change measured in the experiments were converted to proton flux (JH+) by using the equation JH+=ΔpH/Δt×βi, where t equals time. NHE3 activity was calculated as the proton flux in the first 
recovery pulse minus the proton flux in the second recovery pulse.
In vivo measurement of fluid absorption in jejunum
The mice were anesthetized by spontaneous inhalation of isoflurane (Forene: Abbott Germany: Wiesbaden, Germany) via a mask, a catheter was placed in the left carotid artery for continuous infusion 
of (in mM) 200 Na+, 100 CO32‑, 5 K+ and 5 Cl‑ at a rate of 0.3ml/h in ASM+/+ and ASM‑/‑ mice, to maintain 
the systemic acid-base and fluid balance. The procedure for measuring jejunal fluid absorption has been 
previously described in detail [18, 33]. The fluid absorption rates are represented in microliters per 
centimeter jejunum length per hour (μl·cm‑1·h‑1). 
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Intestinal Brush Border Membrane (BBM) IsolationThe lumen of the small intestine was washed with ice‑cold PBS and all the subsequent processes done at 4°C. Intestinal segments were cut open longitudinally and mucosa was harvested by scraping with a glass 
slide and homogenized in 3ml of buffer A (270 mM mannitol, 12 mM Tris, 16 mM HEPES, 1mM EGTA, 1.006 mM CaCl2, pH 7.4, 40µg/ml PMSF, 20µg/ml leupeptin, 20µg/ml pepstatin A, 20µg/ml antipain, 1mM DTT, 4 
mM benzamidin) and homogenized 3 times for 10 secs by means of an Ultra-Turrax homogenizer (IKA) set 
at speed 4, with 10 sec intervals on ice. The homogenate was treated by 20 up and down strokes at 1000rpm 
with a glass on glass potter Potter S (Braun Biotech International). The process of homogenizing was 
repeated at 5 min interval on ice. The homogenate was centrifuged at 2000g, for 10min. Supernatant was collected, samples were taken for homogenate analysis, and 1M MgCl2 was added to a final concentration 
of 10mM with 20 min of mixing and centrifugation at 3000g for 15 min. Supernatant was centrifuged at 
30,000g for 30 min. The pellet was homogenized and suspended in buffer B (270 mM Mannitol, 12 mM 
Tris, 16 mM HEPES, pH 7.4, 40µg/ml PMSF, 20µg/ml leupeptin, 20µg/ml pepstatin A, 20µg/ml antipain, 
1mM DTT, 4 mM benzamidin). 1M MgCl2 precipitation and centrifugation at 3000g for 15 min was repeated. 
The supernatant was centrifuged at 30,000g for 30 min. The pellet was resuspended in TN buffer (50 mM 
Tris-Cl, 150 mM NaCl, pH 7.4, 40µg/ml PMSF, 20µg/ml leupeptin, 20µg/ml pepstatin A, 20µg/ml antipain, 
1mM DTT, 4 mM benzamidin) using a 25G needle. This highly enriched BBM fraction was was used without 
freezing for isolation of DRMs. A small amount of BBM was stored at -80°C for running as a control on PAGE.
Detergent resistant membrane isolation
For isolating lipid rafts, 1mg of the BBM was treated with Triton-X-100, final concentration 1%, in TN 
buffer, up to a volume of 1ml for 30 min with gentle mixing on an orbital rotator. The sample was adjusted 
to 40% by using 2ml of 60% OptiPrep (Axis-Shield, PROGEN Biotechnik, Heidelberg). A step gradient was 
generated by using the 3ml of 40% OptiPrep as the lowermost step and steps of decreasing concentrations 
of OptiPrep- 3.5ml of 35%, 2.5 ml of 25% and 2ml of 15% OptiPrep/TN buffer were overlaid. Centrifugation 
was carried out in a SW-41 Ti Beckman Coulter rotor at 170,000g, for 4h. 1 ml fractions were collected from 
the top and precipitated with 2 volumes of ice-cold acetone, stored at -20°C overnight. The precipitated 
protein pellets were re-suspended in 100µl SDS-PAGE sample buffer at 65°C for 15 min and equal volumes 
of each fraction analyzed by PAGE followed by western blotting.
Immunoblot analysis
Protein samples were resolved on 10% SDS-PAGE, transferred to PVDF membrane (GE Healthcare 
Life Sciences). Blots were blocked and first incubated with primary antibodies overnight at 4°C followed by respective HRP conjugated secondary antibodies for 1hr at room temperature. Blots were developed by 
using ECL (GE Healthcare Life Sciences) and signals quantitated by ImageJ software for gel analysis.
Immunohistochemical analysis of NHE3 distribution along the terminal web‑microvillar axisTo determine the distribution of NHE3 along the terminal web‑microvillar axis of the small intestinal BBM of ASM‑/‑ and ASM+/+ mice, we performed immunohistochemical staining of NHE3 and f‑actin and 
analysed the distribution as previously described [18, 35]. The localisation of the NHE3 as compared to 
f-actin (terminal web) was assessed by ImageJ software as has been previously described in detail [18]. 
The peak value of f-actin profile was taken as reference for plotting the NHE3 profile. For each condition a 
minimum of fifteen cells were taken into consideration from each image. The graph shows the mean of the 
intensity profiles.  
Statistical analysesValues are expressed as mean ± SEM, with the number of experiments (mice or WT and KO pairs) given in parenthesis. Statistical comparisons were either made using a 2‑tailed, unpaired Student’s t test for single‑value comparisons or by ANOVA with post hoc analysis for multiple comparisons. Data was considered 
significant when the p value was less that 0.05.
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Results
Antibody specificity
Figure 1A demonstrates the specificity of anti-NHE3 and anti-NHERF2 and anti-NHERF3 antibodies to detect the respective proteins in the murine small intestinal brush border membrane (BBM). As shown previously, there is cross‑reactivity of the NHERF2 
antibody for NHERF1 (Fig. 1A), but the different size distributions and signal intensities of the proteins allow the separation of the bands by Western analysis (though not by 
immunohistochemistry). Figure 1B shows BBM (different preparations from those utilized in Figure 1A) from NHERF1 KO, NHERF2 KO and WT small intestine, each probed both with the anti‑NHERF1 antibody, as well as with the anti‑NHERF2 antibody. The gel was an 
extra long one, 8% instead of 10% polyacrylamide, designed to separate proteins with little 
difference in size. The anti-NHERF1 antibody stains three bands, all of which are absent in the absence of NHERF1 expression and present in the absence of NHERF2 expression. The anti‑NHERF2 antibody stains 4 bands, two of which are absent in the NHERF1 KO BBM but present in NHERF2 KO BBM, and therefore represent the cross reactivity of the NHERF2 antibody with NHERF1 protein. The uppermost band of NHERF1 seen with the anti‑NHERF1 
antibody is not visualized with the anti-NHERF2 antibody, but is likely NHERF1, because it is absent in the NHERF1 KO BBM.
Fig. 1. Expression of NHE3 and NHERFs in murine BBM. A) Western 
blots depicting antibody specificities 
of a) Antibody against NHE3 (~87 KD) in BBM of Nhe3+/+ and Nhe3‑/‑ mice, b) antibody against NHERF3 (~72 KD) in BBM of Nherf3+/+ and Nherf3‑/‑ mice, and c) the rabbit antibody against NHERF2 cross reacts with NHERF1 as depicted by double bands seen at 
~48 KD for NHERF1 and ~46 KD for NHERF2 in the WT BBM. The ~46 KD bands were absent in Nherf2‑/‑ 
BBM, and the ~48 KD bands were absent in Nherf1‑/‑ BBM. B) This blot displays a different BBM preparation from NHERF1 KO and respective WT, as well as NHERF2 KO and the respective WT, probed with the anti‑NHERF1 antibody (left panel) and the anti‑NHERF2 antibody (right panel). Exposure times were 3 seconds (left panel) and 1 minute (right panel). See explanation in text. It is evident that the anti‑NHERF1 antibody stains three bands, all of which are absent in NHERF1 KO BBM, and does not cross react with NHERF2. The NHERF2 antibody crossreacts with the lower two bands stained by anti‑NHERF1. 
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NHERF PDZ‑adaptors are strongly enriched in the small intestinal brush border
Figure 2 demonstrates the enrichment of NHE3 as well as its interaction partners, ezrin and NHERF1‑3, in the BBM as compared to the homogenate (HG). The divalent cation BBM 
isolation procedure is not specifically limited to isolating integral membrane proteins, but 
also results in the isolation of a significant amount of strongly BBM associated proteins such 
as the cytoskeleton associated proteins ezrin and the sub-apical scaffold forming NHERF-PDZ adaptors, NHERF1, 2 and 3. NHERF1 and NHERF2 were found almost exclusively in the BBM, 
while NHERF3 as well as ezrin was also present in the homogenate in substantial amounts (Fig. 2). In relation to NHERF‑1 and NHERF‑3, the signal for NHERF‑2 is weak at the same 
exposure time of the blot membrane, which reflects the relatively low NHERF-2 expression in relation to NHERF1 and NHERF3 in the murine small intestine [17]. Figure 2 shows the strong association between membrane proteins (i.e. NHE3) and membrane associated 
proteins such as ezrin and the NHERFs. In contrast, the early endosomal marker Rab5 was 
predominantly found in endosomal and trafficking pools in the homogenate.
NHE3 partially associates with rafts in the BBMDRM isolation from enriched BBM of small intestine from WT mice indicated two distinct membrane populations of NHE3 on the basis of distribution of the lipid raft marker 
flotillin2. Flotillin2 was found only in fractions 3-5 which are designated as rafts on the 
basis of OptiPrep densities (25% to 25%-35% interface) (Fig. 3A). Western blot analysis demonstrates that, while the majority of NHE3 is non‑raft associated, there is a population 
of total BBM NHE3 protein (~20%), which associates with membrane rafts (Fig. 3B).
Differential distribution of NHERF1, 2 and 3 with the lipid raft and the non‑raft BBM poolWe next investigated the distribution of individual NHERF PDZ‑adaptors proteins in DRMs from WT enterocyte BBM. We found a differential association of individual NHERF proteins with rafts and non‑rafts (Fig. 3A,B). While NHERF1 associates to a small degree, and NHERF2 to a high degree with lipid rafts, NHERF3 is excluded from rafts and entirely found in the non‑rafts (Fig. 3A,B). Both for NHERF1 as well as for NHERF2, it appears that the upper (larger) of the two bands detected by antibodies for each NHERF is enriched in the lipid raft 
fraction.  We do not currently know why we see multiple bands with very similar size for the 
NHERFs, the most likely explanations are lipid modifications, protein phosphorylation and 
other posttranslational modifications. 
NHE3 and NHERF raft association in the BBM of mice deficient for NHERF1‑3Given the ability of the NHERFs to interact with NHE3, with each other, as well as with other NHE3 “signalosome” interaction partners, our next question was if the expression 
of NHERF1-3 influences the raft and non-raft association of NHE3, or of each other. We 
Fig. 2. Western analysis of brush border membrane association of the proteins under study. Western blots for BBM (left lanes) and 
cellular homogenate (HG) (right lanes) for ezrin, 
NHE3, NHERF1, NHERF2, NHERF3, flotillin2 and rab5 (three independent preparations from three mice). NHERF1 and NHERF2, albeit not transmembrane proteins, show a very strong 
membrane association, ezrin and NHERF3 to a lesser degree, and rab5 not at all. 
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A B
C D
Fig. 3. NHE3 is partially as‑sociated with lipid rafts, and the different NHERFs are dif‑ferentially asso‑ciated with the raft and non‑raft fraction of BBM. A) NHE3 and the NHERF‑PDZ adaptors in rafts and non‑rafts of WT mice. Ap‑
prox. 20% of to‑tal BBM NHE3 is found in the raft fractions, which are indicated as fractions 1‑5. NHERF1 shows very little raft a s s o c i a t i o n , NHERF2 asso‑ciates strongly with rafts, and NHERF3 is ab‑sent from the raft fractions. C), NHERF1 abla‑tion resulted in increased NHE3 and NHERF2 in rafts. E), NHERF2 KO BBM show a decrease in NHE3 in intes‑tinal rafts, dem‑onstrating that 
E F
G H
NHE3 association with rafts is influenced by the presence of NHERF-2. G) NHERF3 KO BBM show an in‑crease of NHERF1 and NHERF2 raft‑association. The Western results correspond to 2‑4 independent lipid 
raft isolations from BBM pooled from 4 mice each. B) Quantification of immune signals from A) NHERF 
WT BBM showed NHE3 (18%±0.16) and NHERF2 (41%±0.72) in rafts, while NHERF1 raft-association was 
not significant (2%±1.03) and NHERF3 not present at all, D) NHERF1 KO showed a significant increase in 
raft-associated proteins, NHE3 (34.2%±9.1) and NHERF2 (51%±4.4), F) NHERF2 KO showed a strong de‑
crease in NHE3 (3.7%±2.7). H) NHERF3 KO BBM showed an increase of NHERF2 (78%±7.6) and NHERF1 
(11%±2.56), but not of NHE3, in the raft fraction. n=2-4, p>0.05.
therefore studied NHE3 raft association in the small intestine of mice lacking NHERF1, NHERF2 or NHERF3. Compared to WT, in NHERF1 KO enterocyte BBM, raft‑association was 
higher for NHE3 (34%±9.1) and for NHERF2 (51%±4.4) (Fig. 3 C,D). NHERF3 was again non‑raft associated, identical to the situation in WT (Fig. 3 C,D). 
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In NHERF2 KO enterocyte BBM, we observed a reduction of NHE3 localisation to rafts. NHERF1 and NHERF3 associations were unaltered (Fig. 3 E,F). The marked decrease of NHE3 in raft microdomains suggests that NHERF2 is involved in targeting and/or retention of NHE3 in rafts. Thus, among the NHERFs, NHERF2 emerges as the potential NHERF candidate modulating the transport activity of the lipid raft‑associated NHE3 population. NHERF3 KO BBM showed a higher percentage of NHERF1 and NHERF2 in rafts (Fig. 3 G,H), but not of NHE3. These data indicate that the NHERF PDZ‑adaptors, possibly due to their binding to 
NHE3 as well as to each other, are involved in regulating the localization of NHE3 and of each other to different membrane microdomains. 
Raft association of NHE3 in DRA KO and PAT‑1 BBMThe established functional interaction partner of NHE3 is the anion exchanger DRA (Slc26a3), which has been demonstrated to be important for small intestinal Cl‑ absorption 
[36, 37]. Like NHE3, DRA has a PDZ binding motif and binds to NHERF-2 and NHERF-3 [38, 
39], has been shown to be raft-associated [40], and has been proposed to cluster with NHE3 
during salt absorption [38, 12]. We therefore asked the question whether DRA may function as an assembly protein for NHE3 into the rafts. However, the distribution of NHE3 (Fig. 3A,B), 
A B
C D
Fig. 4. NHE3 raft-association is independent of DRA expression and NHE3 cosegregates with ezrin in both the raft and the non‑raft fractions. A) Flotillin2 and NHE3 raft‑association in BBM of WT and DRA KO mice 
are similar, implying that NHE3 localizes to rafts independently of its possible physical interaction with 
DRA. B) Quantitative analysis of immune signals for flotillin2 and NHE3 in WT and DRA KO BBM. n=2-3. 
C,D) Ezrin (81kD) bands appear in both the raft and the non-raft fraction in C56B/6 WT BBM. A similar distribution was observed in the FVB/N WT BBM (data not shown) n=3.
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as well as the NHERFs (data not shown) into raft and non-raft fractions was not significantly altered in the BBM of DRA KO small intestine (Fig. 4A,B). Another interaction partner of NHE3, less well established, is the Slc26 family member PAT‑1 (Slc26a6) [41], but its absence 
also did not significantly influence NHE3 raft association (data not shown).  
Ezrin association with rafts
Ezrin, known to bind both to NHERF1 and NHERF2 via their ERM domain, as well as 
directly to NHE3 [see 8, 11, for review], was found to strongly cosegregate with NHE3 and NHERF2 into the same raft fraction, but was also present in the non‑raft BBM fraction (Fig. 4 C,D).  
Raft‑associated NHE3  in the murine small intestinal BBM is functionally active.
Similar to NHE3 in the BB of opossum kidney cells [20], a decrease in acid-activated NHE3 activity of the enterocytes within micro‑dissected jejunual villi was observed upon depletion 
of cholesterol from the apical membrane by MβCD perfusion (Fig. 5). Cholesterol depletion 
in cells via MβCD may have additional effects on transport proteins (i.e. reorganization of cellular actin cytoskeleton reducing lateral mobility of both raft and non‑raft proteins at 
the cell surface [42, 43], depolarization of plasma membrane and non-specific depletion of intracellular Ca2+ stores [44]. Therefore we sought another means of altering raft lipids. 
The enzyme acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide [45]. In 
ASM-deficient mice, plasma membranes have a higher sphingomyelin/ceramide ratio, as well as ganglioside content compared to those in wild type counterparts [46]. This change 
in lipid metabolism also affects the DRM lipid composition [47, 48]. We therefore assessed the association of NHE3 with DRMs in ASM KO jejunal BBM. In WT jejunum (C57BL/6 
Fig. 5. Modulation of NHE3 activity by cholesterol extraction. A) Schematic dia‑gram of the villus perfusion chamber, and screenshot of BCECF‑loaded villus with areas of interest (ROI) outlined. The villus has changed its dimension since place‑ment of the ROIs, and the stored images of each experiment are rerun and the ROIs retraced after its completion. Pseudoco‑
lours indicate the 490/440 ratio. B) The activity of NHE3 in membrane rafts was estimated by measuring acid‑activated Na+-dependent proton flux (mM/min) before and after disruption of rafts us‑
ing 10mM MβCD superfusion for 10 min. 
NHE3 activity was reduced by ~22% after 
MβCD treatment. n=4 (p<0.05).
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background), a significant fraction of BBM NHE3 associated with membrane rafts (Fig. 6A,B), similar to the results from WT FVB/N jejunum. Interestingly, in ASM KO mice, a shift of both 
flotillin2 and NHE3 towards even lighter density fractions was observed (Fig. 6A). There 
was a concomitant increase in overall NHE3 (41.8%±2) association with the raft fractions 
(Fig. 6B). The fraction of ezrin in the rafts did not appear to be altered (26,1% in WT vs 28% 
in KO), but the numbers of raft preparation tested for ezrin distribution were too low for statistical evaluation. To study the functional consequences of a change in membrane lipid composition and a higher percentage of NHE3 in membrane rafts, we measured jejunal basal, acid‑activated (by luminal CO2/HCO3‑ perfusion), and forskolin-inhibited fluid absorptive rates in vivo. Basal 
fluid absorptive rate was significantly higher in ASM KO (131±9.5 µl·cm‑1·h‑1) compared to 
WT jejunum (106±7.4 µl·cm‑1·h‑1),p<0.05. Upon subsequent intracellular acidification of the jejunal enterocytes by perfusing the lumen with CO2/HCO3‑, pH 7.4, a similar increase in 
NHE3 activity was observed, both in WT (186±10.4, 35.6% increase from basal) and ASM KO 
jejunum (234±18.4, 34.9% increase from basal) (Fig. 7, left and middle bars). Treatment by 
10µM forskolin resulted in a significant decrease in NHE3 activity in WT mice, but not in ASM KO mice (Fig. 7, right bars). 
Fig. 6. Membrane raft asso‑ciation of NHE3 and NHERFs is altered by a change in lipid composition of BBM. A) In the ASM KO mice, NHE3 was distributed into rafts and non‑rafts, but there was a pro‑
nounced shift of both flotillin2 and NHE3 towards even light‑er density OptiPrep fractions which we denote as “lighter rafts” (L‑rafts). B) Quantita‑tive analysis showed that there was a twofold increase in NHE3 
pool in rafts in ASM KO, 50% of 
which was localized in L-rafts 
(p<0.05). n=3.
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The localization of NHE3 along the microvillar axis in the BBM was not altered in ASM KO jejunum, as indicated by a similar distribution of the relative NHE3‑mediated pixel intensity perpendicular to the terminal web‑microvillar axis in relation to F‑actin (Fig. 
8A), and neither the steady-state pHi, (Fig. 8B), nor the maximal NHE3 transport rate after 
Fig. 7. Modulation of sphingolipid composi‑
tion of BBM alters small intestinal fluid absorp‑
tive rates. Basal fluid absorption in vivo (~60% mediated by NHE3), and CO2/HCO3‑‑stimulated 
fluid absorption (the stimulation being ~100% NHE3‑dependent) were significantly higher in ASM KO than WT jejunum, while decrease in 
fluid absorption by 10 μM forskolin treatment 
only reached the level of significance in WT jeju‑
num. WT n=10 and ASM KO n=9, (p<0.05). 
Fig. 8. NHE3 BBM localization and acid‑activated NHE3 activity was unaltered in ASM KO jejunum. A) NHE3 distribution along the termi‑nal web‑microvillar axis was simi‑lar in ASM KO and WT jejunal BBM. F‑actin (red) was stained by phal‑loidin, NHE3 (green) by antibody staining, and the relative intensity distribution along the microvillar axis was analysed as described in the method section. The peak of F‑actin intensity denotes the terminal web/microvillar cleft region, and 
the majority of NHE3 was localized to the microvillar region (more toward the lumen) in ASM KO as well as WT jejunum. B) The steady state pHi, assessed fluorometri‑cally in the enterocytes of jejunal villi from ASM WT and KO mice, 
was not significantly different. WT 
n=11 and ASM KO n=10 (p<0.05). C) The acid‑activated NHE3 trans‑port rate (which will measure the total membrane‑resident NHE3 pool) was also similar for WT and ASM KO mice. WT n=16 and ASM 
KO n=12 (p<0.05).
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ammonium-prepulse-induced intracellular acidification (Fig. 8C), which assesses the total 
activatable NHE3 pool, was different in microdissected jejunal ASM-deficient and WT villi.
DiscussionOur data suggest that native murine small intestinal enterocytes have two distinct pools of NHE3 in the BBM, a lipid raft‑associated and a non‑raft‑associated pool. This is in 
accordance with earlier findings in rabbit ileum [19]. The different NHERF adaptor proteins (NHERF1‑3) were found to differentially co‑segregate with the raft and non‑raft fraction of NHE3 in the BBM. NHERF2 was strongly associated with lipid rafts in the BBM, whereas NHERF1 and NHERF3 were not. The data also suggested that the presence of the NHERFs 
influence the raft association of NHE3, as well as of each other. In a mouse model with a genetic alteration of membrane lipid composition, a higher percentage of NHE3 in the lipid 
rafts in small intestinal BBM was associated with a higher basal fluid absorptive rate and with less sensitivity to inhibition by FSK. Thus, one reason for the different regulatory functions of this highly homologous family of proteins may be mediated via their association with different pools of NHE3. 
The molecular identification of the NHERF proteins as regulators of NHE3 transport function occurred during the search for NHE3 binding proteins that were required 
for PKA-mediated inhibition of NHE3 transport activity [see 8, 11 for review]. In PS120 
fibroblasts, either NHERF1, or NHERF2, was required but sufficient to form a complex 
between NHE3 and the PKA anchor protein ezrin, bringing PKA into close proximity to 
NHE3 (hypothetized to be then phosphorylated and thus inhibited) [49]. However, when 
NHE3 regulation was first studied in the native intestine and the proximal tubule of 
NHERF1-3-deficient mice, the lack of each NHERF resulted in a specific loss of a subset of regulatory aspects of NHE3 regulation and/or of membrane retention in a signal‑ and segment 
specific manner, despite the fact that all three NHERFs were expressed in both enterocytes 
and in proximal tubule epithelium [14-18]. In murine intestine, the loss of NHERF3, but not of NHERF1 or NHERF2, resulted in a decrease in acid‑activated NHE3 activity as well 
as of cAMP-mediated NHE3 inhibition [15-18]. Although a multitude of additional NHE3 
interacting proteins have been identified in the meantime, it is still unclear what determines 
the specific interaction of one member of the NHERF family, and not the other, with NHE3 in a given signaling event. One explanation would be that NHE3 exists in different pools within the brush border membrane, and these pools are differentially targeted by the different NHERFs. Associations of membrane proteins within membrane rafts (lipid rafts) is another 
mode of assembly of membrane proteins [21, 24, 50]. In rat proximal tubule, NHE3 and the Na+ phosphate co‑transporter NaPiII, which both bind to and are regulated by NHERF1, associate with different membrane microdomains [22, 23]. NHE3 was predominantly lipid raft‑associated, whereas NaPiII was non‑raft associated, and NHERF1 was found only in the non‑raft fraction during angiotensin II‑mediated inhibition of sodium and phosphate absorption [23]. In the rabbit ileum, NHE3 was found to associate with lipid rafts to a lesser degree than in rat kidney [19], this paper, suggesting that in the intestinal BBM, at least two NHE3 pools exist – a small raft and a larger non‑raft pool.
We hypothesized that the different NHERFs, which all mediate NHE3 inhibition, but do so in response to different agonists or in different cell types, may differentially associate with the raft and the non‑raft pool of NHE3 in the murine small intestinal brush border membrane. This was indeed the case, although not in the way we expected. We had assumed that the fact that NHERF1 was shown to be important in cAMP‑mediated inhibition of renal but not intestinal NHE3 [14, 15], whereas NHERF3 (PDZK1) was required for intestinal NHE3 inhibition [16, 17], may be due to NHERF1 and NHERF3 interacting with different NHE3 pools, NHERF1 with a non‑raft associated pool of NHE3 (in analogy with the kidney) and NHERF3 with a lipid raft‑associated pool of NHE3. Instead, we found NHERF2 to be 
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highly raft‑associated, NHERF1 only weakly, and NHERF3 to be entirely non‑raft associated. 
This finding may explain why, in the murine intestine, certain signaling pathways are exclusively NHERF2‑dependent, yet only affect a fraction of NHE3 function. For example, the acute stimulation of NHE3 by lysophosphatidic acid [35], and the acute inhibition of 
NHE3 by heat-stable Eschericia coli enterotoxin, as well as by carbachol [18], only affected a 
fraction of total acid-activated NHE3 function [18, 35]. One of several  potential explanations may be that these signaling pathways, because of their NHERF2 dependency, preferentially or exclusively target the raft‑associated pool of NHE3 in the plasma membrane. Of course, many future experiments are necessary to understand the dynamics of NHE3 and NHERF2 into and from the membrane rafts of native intestinal BBM.   We next addressed the question whether the segregation of NHE3 to lipid rafts may 
be influenced by the NHERFs. While the NHERFs are not integral membrane proteins and would not be able to integrate into the membrane portion of the raft, they may either bind to other raft‑associated proteins and thus tether NHE3 to the rafts, or they may target to rafts 
because of lipid modifications. One such scenario has been found during the study of the 
cAMP-induced inhibition of the T-cell response, where ezrin brings PKA into proximity with its downstream substrate Csk in lipid rafts by forming a multiprotein complex consisting 
of PKA-Ezrin-NHERF1-Csk, via the Csk-binding protein/phosphoprotein associated with glycosphingolipid‑enriched microdomains (PAG) [51‑53]. Therefore we investigated the raft 
association of NHE3 in BBM isolated from NHERF1-3 deficient mice. The striking finding was a decrease in the raft‑associated NHE3 pool in the absence of NHERF2 expression, while it was preserved in the absence of NHERF1 or NHERF3. The absence of NHE3 expression, on 
the other hand, did not influence the differential association of the NHERFs to the raft and non‑raft fraction in the BBM (data not shown). The absence of NHERF1 appeared to increase the raft association of both NHE3 and NHERF2, while the absence of NHERF3 increased the raft association of NHERF1 and NHERF2. The explanation may be the NHERFs bind to each other [54, 55], and the high abundance of NHERF1 in the intestine may tether both NHERF2 
and NHE3 to a non-raft localization. We also investigated whether other raft‑associated, NHE3‑ as well as NHERF‑2 interacting partners such as Cl‑/ HCO3‑ exchangers Slc26a3 (DRA), and Slc26a6 (PAT1), may tether either NHERF‑2 or NHE3, or both, to the rafts, but the absence of either anion 
exchanger did not influence the raft association with either NHE3 (Fig. 3A,B) or the NHERFs 
(data not shown). Ezrin, which binds both the NHERF2 as well as to NHE3 [8, 11], was found to cosegregate both with the raft and the non‑raft fraction (Fig. 4C,D), and it would 
be interesting to study raft association in the absence of ezrin, but the ezrin KO mice die early [56]. Thus, future experiments will be necessary to elucidate the molecular basis for the strong raft association of NHERF2. Membrane raft targeting of proteins is often effected 
through lipid modifications such as palmitoylation [57]. Whether the NHERF-2 itself binds to rafts, or whether a palmitoylated and/or GPI‑anchored NHERF‑binding protein such as 
PAG [51-53], or CD371/tetherin [58] has binding affinity to NHERF-2 and may act as the intermediate, needs further study. The method of isolating DRMs has been implicated in experimentally “creating” large and stable lipid rafts, whereas in the natural state they may be highly dynamic and 
nanoscale in size [21, 59]. In addition, the cholesterol depletion of the membrane by MβCD treatment is a frequently employed technique to study the functional importance of raft association of a protein, but this method may cause additional alterations in the plasma 
membrane, such as a reorganization of cellular actin cytoskeleton reducing lateral mobility 
of both raft and non-raft proteins at the cell surface [42, 43]. MβCD has also been reported 
to induce depolarization of plasma membrane and non-specific depletion of intracellular Ca2+ stores [44], and it may affect membrane curvature or membrane surface charge, 
thus interfering with NHE3 activity [1, 6, 10]. Therefore we sought for another means of altering raft lipids and studying the effect on NHE3 raft association and possibly, function. 
The ASM hydrolyzes sphingomyelin to ceramide, and ceramide molecules coalesce to form 
large ceramide-enriched rafts [45]. We speculated that one way of influencing membrane 
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rafts by a genetic approach would be to study small intestinal brush border membranes of 
ASM-deficient mice. These mice have higher serum cholesterol and a higher percentage of glycolipids and gangliosides in their plasma membrane, which also causes changes in lipid 
raft composition [46-48]. We found the lipid rafts from ASM-deficient mice to have a lower 
buoyant density (as judged by the shift of flotillin2 to lighter density fractions of the optiprep gradient) and we found a higher percentage of BBM NHE3 to be associated with lipid rafts. 
The mice also had a significantly higher basal and CO2/HCO3‑ stimulated fluid absorptive rate in vivo, which is a function of active NHE3 in the microvillar region [37]. The maximal acid activation of NHE3 by ammonium prepulse in vitro, which is expected to activate all 
membrane resident NHE3, was not significantly different in ASM-deficient compared to WT 
villi, and neither was the percentage of NHE3 localized to microvilli (as compared to the microvillar cleft/terminal web region, which is the region with maximal F‑actin staining) 
altered in these mice. Interestingly, the inhibition of fluid absorptive rate by forskolin was 
significant only in WT mice, suggesting that the NHERF-2 and raft-associated pool of NHE3 may not be the one inhibited by an increase in intracellular cAMP levels. This is consistent 
with previous observations in the NHERF-deficient mice, where the lack of NHERF3 and to 
some extent NHERF-1, but not of NHERF2 influenced cAMP-mediated NHE3 inhibition in 
the intestine [15-18]. It is also consistent with work by Murtazina et al in opossum kidney 
cells, where NHE3 raft association was not essential for cAMP inhibition of NHE3 [20]. These 
are the first in vivo experiments confirming that changes in membrane lipid composition as well as increased NHE3 raft association may affect NHE3 activity, but the model is clearly too 
complex to firmly establish the molecular basis for the change in NHE3 raft association as 
well as increase in NHE3-mediated fluid absorption. Additional modes of NHE3 regulation, such as membrane curvature, surface charge, or altered protein complex assemblies due to 
changes in lipid modification of proteins, may also affect the regulation of NHE3-mediated 
fluid absorption in ASM-deficient mice. In summary, we found that the Na+/H+ exchanger isoform NHE3 exists in two pools in the small intestinal brush border membrane, one found in a detergent‑resistant (“lipid raft”) membrane fraction, and one not raft‑associated. Different NHE3‑regulatory NHERF proteins differentially associate with the raft and non‑raft pools of NHE3, with NHERF2 being most raft‑associated and NHERF3 precluded from rafts. Moreover, NHE3 raft‑association was decreased in the absence of NHERF2. This suggests that PDZ adaptor proteins are involved in the tethering of NHE3 to lipid rafts, thus enabling the spatial separation of NHE3 into different pools within the intestinal brush border membrane. Because it has been shown that 
the lipid environment of the surrounding membrane influences NHE3 transport activity [6, 
10], it is also possible that the association of NHE3 with lipid rafts may result in functionally different NHE3 membrane pools. The differential association of the different NHERFs with the raft and non‑raft pool of NHE3 may allow signaling molecules to selectively target these different pools of NHE3. The molecular mechanisms and functional consequences of different NHE3‑NHERF pools in the intestinal brush border membrane need to be further 
explored. This may, eventually, result in drug development strategies that specifically target pathophysiologically important, NHERF‑mediated NHE3 over‑ or underfunction. 
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